The study found patients who used mHealth applications had better health outcomes and were able to regulate their health behavior more effectively than patients who did not use these apps, in addition to fewer hospital visits and lower medical costs.
Systemic inflammation associated with RA may contribute to the risk of a patient developing type 2 diabetes.
The National DPP is an evidence-based lifestyle change program designed to delay or prevent the onset of type 2 diabetes among adults with prediabetes.
Patients with diabetes have a higher risk of cardiovascular disease and heart failure.
The study measured immune responses from individuals genetically predisposed to developing T1D to naturally occurring insulin and hybrid insulin peptides.
One-third of study participants treated with semaglutide lost at least 20% (46 pounds) of their baseline weight, which is a common reduction for many patients who have had bariatric surgery in the 1 to 3 years following their procedure.
The objective of the study was to determine the impact of goldenseal on specific drug transporters, proteins that facilitate absorption or expulsion of drug molecules in different tissues, such as the intestine, liver, and kidney.
The two paired trials evaluated sotagliflozin, a drug that inhibits SGLT2 and SGLT1, according to a study published in The New England Journal of Medicine.
Attaining healthy blood sugar levels after pregnancy did not decrease the risk of developing cardiovascular disease in mid-life for women with a history of gestational diabetes.
Research shows that closed-loop systems can increase time in range and reduce both hyperglycemia and hypoglycemia in youth and young adults.
The program educates patients on how to use the FreeStyle Libre 2 system as well as ways to positively impact their glucose levels through diet and fitness.
How health system specialty pharmacies can leverage data to differentiate the impact of the high-touch, integrated care model and create value for all pharmacy stakeholders.
Although eating healthier food and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.
With increasing rates of diabetes and its risk factors, the researchers emphasized the urgency of developing effective interventions.
Additional randomized clinical trials are warranted to determine the mechanism between the 2 diseases.
Study finds that death was significantly less likely for type 2 diabetes subjects taking metformin, compared to those not taking metformin.
Low carbohydrate diets also increased weight loss, reduced medication use, and improved body fat concentrations at 6 months.
The study authors noted that although the Western diet does not promote good cardiovascular health, it is not clear exactly what contribution fried food might make to the risks of serious heart disease and stroke.
The use of artificial sweeteners has increased dramatically over the past decade due to growing awareness of the negative health outcomes associated with consuming too much sugar.
Limitations of the study included the sample size of the participants and a gender imbalance across the groups, with more women randomized to bimagrumab and more men to the placebo.
Diabetes and stress-induced hyperglycemia affect an estimated 30% to 45% of all hospitalized patients.
The analysis found that at least 38 minutes of moderate intensity exercise each day was associated with the lower risk, which is a little more than the current recommendations of at least 30 minutes a day, 5 days a week.
New research suggests immunosuppressants do not increase the risk of COVID-19.
The objective of the study was to evaluate the impact of the ambulatory care pharmacist intervention on A1C changes in patients with uncontrolled type 2 diabetes mellitus (T2DM) during a 2-year period at the diabetes education center.
Educating patients about medication adherence and understanding and monitoring A1C and fasting glucose levels improves health outcomes.
